Cargando…
Purposing Saikosaponins for the treatment of COVID-19
Autores principales: | Bahbah, Eshak I., Negida, Ahmed, Nabet, Mohamed Salah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179490/ https://www.ncbi.nlm.nih.gov/pubmed/32353743 http://dx.doi.org/10.1016/j.mehy.2020.109782 |
Ejemplares similares
-
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
por: Abdel-Maboud, Mohamed, et al.
Publicado: (2020) -
Do cerebral microbleeds increase the risk of dementia? A systematic review and meta-analysis
por: Hussein, Ahmed Salah, et al.
Publicado: (2022) -
Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis
por: Negida, Ahmed, et al.
Publicado: (2021) -
Should the direct aspiration first pass technique be advocated over the stent-retriever technique for acute ischemic stroke? A systematic review and meta-analysis of 7692 patients
por: Negida, Ahmed, et al.
Publicado: (2021) -
Aortic Dissection: A Review of the Pathophysiology, Management and Prospective Advances
por: Sayed, Ahmed, et al.
Publicado: (2021)